tetano
Editor, Senior Moderator
Infect Control Hosp Epidemiol
. 2022 Aug 22;1-5.
doi: 10.1017/ice.2022.201. Online ahead of print.
The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study
Ornnicha Sathitakorn[SUP] 1 [/SUP], Siriththin Chansirikarnjana[SUP] 2 [/SUP], Kittiya Jantarathaneewat[SUP] 3 4 [/SUP], David J Weber[SUP] 5 [/SUP], David K Warren[SUP] 6 [/SUP], Piyaporn Apisarnthanarak[SUP] 7 [/SUP], Pichaya Tantiyavarong[SUP] 8 [/SUP], Anucha Apisarnthanarak[SUP] 1 4 [/SUP]
Affiliations
Abstract
In this quasi-experimental study, implementing a procalcitonin and Clinical Pulmonary Infection Score (CPIS) successfully reduced inappropriate antibiotic use among severely-to-critically ill COVID-19 patients, multidrug-resistant organisms, and invasive fungal infections during the intervention period in 2 medical centers. However, this strategy did not improve inappropriate antibiotic use among mildly-to-moderately ill COVID-19 patients.
. 2022 Aug 22;1-5.
doi: 10.1017/ice.2022.201. Online ahead of print.
The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study
Ornnicha Sathitakorn[SUP] 1 [/SUP], Siriththin Chansirikarnjana[SUP] 2 [/SUP], Kittiya Jantarathaneewat[SUP] 3 4 [/SUP], David J Weber[SUP] 5 [/SUP], David K Warren[SUP] 6 [/SUP], Piyaporn Apisarnthanarak[SUP] 7 [/SUP], Pichaya Tantiyavarong[SUP] 8 [/SUP], Anucha Apisarnthanarak[SUP] 1 4 [/SUP]
Affiliations
- PMID: 35993305
- DOI: 10.1017/ice.2022.201
Abstract
In this quasi-experimental study, implementing a procalcitonin and Clinical Pulmonary Infection Score (CPIS) successfully reduced inappropriate antibiotic use among severely-to-critically ill COVID-19 patients, multidrug-resistant organisms, and invasive fungal infections during the intervention period in 2 medical centers. However, this strategy did not improve inappropriate antibiotic use among mildly-to-moderately ill COVID-19 patients.